Zimmer Biomet (ZBH) Competitors

Solventum (NYSE:SOLV) and Zimmer Biomet (NYSE:ZBH) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends, community ranking and media sentiment.

Do analysts rate SOLV or ZBH?

Solventum currently has a consensus price target of $68.00, indicating a potential downside of 3.89%. Zimmer Biomet has a consensus price target of $123.22, indicating a potential upside of 11.27%. Given Zimmer Biomet's stronger consensus rating and higher possible upside, analysts plainly believe Zimmer Biomet is more favorable than Solventum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solventum	1 Sell rating(s)	8 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Zimmer Biomet	2 Sell rating(s)	12 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.20

Does the MarketBeat Community favor SOLV or ZBH?

Zimmer Biomet received 898 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 67.24% of users gave Zimmer Biomet an outperform vote while only 5.88% of users gave Solventum an outperform vote.

Company	Underperform	Outperform
Solventum	Outperform Votes 1 5.88%	Underperform Votes 16 94.12%
Zimmer Biomet	Outperform Votes 899 67.24%	Underperform Votes 438 32.76%

Do insiders and institutionals hold more shares of SOLV or ZBH?

88.9% of Zimmer Biomet shares are held by institutional investors. 0.7% of Zimmer Biomet shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Which has stronger earnings and valuation, SOLV or ZBH?

Zimmer Biomet has higher revenue and earnings than Solventum.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solventum	N/A	N/A	N/A	N/A	N/A
Zimmer Biomet	$7.60B	2.90	$1.02B	$5.26	21.05

Does the media prefer SOLV or ZBH?

In the previous week, Zimmer Biomet had 5 more articles in the media than Solventum. MarketBeat recorded 23 mentions for Zimmer Biomet and 18 mentions for Solventum. Solventum's average media sentiment score of 1.56 beat Zimmer Biomet's score of 0.82 indicating that Solventum is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Solventum	17 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Zimmer Biomet	17 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is SOLV or ZBH more profitable?

Zimmer Biomet has a net margin of 14.27% compared to Solventum's net margin of 0.00%. Zimmer Biomet's return on equity of 12.95% beat Solventum's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solventum	N/A	N/A	N/A
Zimmer Biomet	14.27%	12.95%	7.55%

Summary

Zimmer Biomet beats Solventum on 12 of the 13 factors compared between the two stocks.